Valuation : Proto Script Pharmaceutical Corp.

Market Cap 1.97M 1.7M 1.59M 1.45M 2.73M 187M 2.75M 18.85M 7.34M 94.89M 7.38M 7.22M 315M P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 2.01M 1.74M 1.63M 1.49M 2.8M 191M 2.81M 19.31M 7.52M 97.2M 7.56M 7.4M 322M EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
1 day-50.00%
1 week-50.00%
1 month-50.00%
3 months-50.00%
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
2.2
Manager TitleAgeSince
Chief Executive Officer 58 2016-06-28
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%-50.00%-90.00%-98.00% 5.69K
-0.59%-2.04%-4.49%+58.80% 80.27B
-1.82%-3.01%+0.07%+8.09% 17.13B
-0.74%-2.60%+5.51%+9.05% 14B
+0.04%-0.09%+27.01%+39.81% 12.13B
-1.59%-3.89%+18.24%+82.98% 8.01B
-0.63%-3.14%+54.66%+132.24% 6.94B
-0.76%+1.18%-16.87%-0.37% 6.33B
-1.73%-0.08%-14.53%+27.71% 5.67B
+0.38%+2.15%+14.85%-0.52% 5.31B
Average -5.74%-0.74%-0.56%+25.98% 15.58B
Weighted average by Cap. -0.76%-1.63%+2.95%+46.23%

Financials

2015 2016
Net sales 881K 760K 715K 652K 1.23M 83.65M 1.23M 8.46M 3.29M 42.55M 3.31M 3.24M 141M 789K 681K 640K 583K 1.1M 74.88M 1.1M 7.57M 2.95M 38.09M 2.96M 2.9M 126M
Net income -145K -125K -118K -107K -202K -13.79M -203K -1.39M -542K -7.01M -545K -534K -23.25M -7.18M -6.2M -5.83M -5.31M -9.98M -682M -10.04M -68.9M -26.82M -347M -26.97M -26.38M -1.15B
Net Debt 27.07K 23.35K 21.96K 20.01K 37.63K 2.57M 37.83K 260K 101K 1.31M 102K 99.43K 4.33M 47.78K 41.22K 38.77K 35.32K 66.42K 4.53M 66.78K 458K 178K 2.31M 179K 176K 7.65M
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PSCR Stock